Navigation Links
An effective strategy for inhibition of cirrhosis
Date:9/24/2008

In China, the incidence of liver cirrhosis is still high, although new therapeutic approaches have recently been proposed, there is no established therapy for liver fibrosis, and Authors investigated the prevention effects of Chinese Medicine Qianggan-Rongxian Soup on liver fibrosis induced by DMN in rat. Chinese Medicin Qianggan-Rongxian decoction can inhibit hepatic fibrosis resulted from chronic liver injure, retard the development of cirrhosis, and notably ameliorate the liver function. It may be a safe and effective therapeutic drug for patients with fibrosis.

A research article to be published on 14 June 2008, in the World Journal of Gastroenterology addresses this question. The research team led by Chun-Hui Li from affiliated Hospital of Chengde Medicine College studied the inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat.

Qianggan-Rongxian decoction, especially the medium-dose administration could decrease the area-density percentage of collagen fibrosis. HA, LN, and type IV collagen are good serum markers of hepatic fibrosis. In this study, the serum contents of these 3 markers in the model group were much higher than those of the controls. And the Qianggan-Rongxian decoction groups had significantly low HA, LN, and type IV collagen levels in serum than those in the controls, ALT and AST are indexes to describe liver functions. Most part of ALT is presented in the cytoplasm of liver cell, discharged in blood when degeneration, hyper permeability and necrosis of liver cells occur. So the increase of ALT level in serum reflects the degree of liver cell injury. Our study showed that the Qianggan-Rongxian decoction could decrease serum levels of ALT and AST in rats with hepatic injury caused by DMN. It indicates that Qianggan-Rongxian decoction may work through protecting the liver cells, which indicated that Qianggan-Rongxian decoction could successfully prevent hepatic fibrosis.

The mechanism of DMN-induced liver fibrosis has been shown to be associated with immune function, which is similar to the mechanism of human liver fibrosis. Thus, DMN-induced rat liver fibrosis may be a useful model for determination of liver fibrosis during drug screenin. The mechanism of the Qianggan-Rongxian decoction may need further research.

This study may provide a safe and effective strategy for inhibition of cirrhosis in clinic use.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Use of certain lipid measures not more effective in predicting coronary heart disease
3. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
4. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
5. Stanford study highlights cost-effective method of lowering heart disease risks
6. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
7. Case Management Cost-Effective Way to Cut Heart Risks
8. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
9. Nasal Anthrax Vaccine Proves Effective in Animal Study
10. Family-based treatment more effective than supportive psychotherapy in treating bulimia
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... , ... SC&H Group, a leading audit, tax, and consulting firm, announced that ... Services practice . Rossi is the third technology consulting leader to join SC&H Group’s ... and the practice continues to expand.     , Bringing more than 25 years of business ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians ... Sandra Lee as keynote speaker for the 34th Annual Miami Breast Cancer Conference®, ... the announcement, PER® president, Phil Talamo, said, “We are delighted to have Sandra ...
(Date:1/17/2017)... ... ... people make New Year’s resolutions or renew their commitment to better health with the start ... who want to kick off 2017 with better smiles. Dr. Mondavi is offering several promotions ... include: , , A new patient package for just $49, which ...
(Date:1/16/2017)... ... January 17, 2017 , ... To provide comfort and fuel ... the fast-casual category, announces a hearty and wholesome Winter Menu. Starting today, guests ... Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage ...
(Date:1/16/2017)... , ... January 16, 2017 , ... Gym Source, America’s ... a new showroom in East Hanover, New Jersey. , “We are elated to be ... new innovative in-store concept is designed to give clients a seamless and motivating shopping ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan 17, 2017 Research and Markets ... System Market 2016-2020" report to their offering. ... The global artificial pancreas devices ... period 2016-2020. Global Artificial Pancreas Devices System Market 2016-2020, ... from industry experts. The report covers the market landscape and its ...
(Date:1/17/2017)... Jan. 17, 2017 Paragon Bioservices received a ... development services for a variety of National ... medical product development activities. The IDIQ mechanism will ... for task order awards up to $159 million. ... manufacturing and process development of biopharmaceuticals, is one ...
(Date:1/17/2017)... , Jan. 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... has been enrolled in a Phase 3 clinical trial ... supportive care (BSC) in the prevention of hepatic veno-occlusive ... stem cell transplant (HSCT) who are at high risk ... defibrotide clinical trial will be conducted across approximately 100 ...
Breaking Medicine Technology: